Abstract
The engineering of particles with customized properties optimized for dosage form manufacture (tablet, capsule, ointment, etc.) has long been a goal of the pharmaceutical industry. Particles can be designed through modification in the size, morphology, and packing arrangement of the solids. The most common approach in achieving this is through crystallization. In this bottom-up process, the two main steps, nucleation and crystal growth, both play a decisive role in shaping the quality of the final crystalline product. In this review, the role of nucleation and crystal growth in controlling particle properties is discussed, and examples are provided that demonstrate the variation in solid-state properties as a function of size, habit (morphology), and internal structure of the particles. In addition, the role of particle properties in product performance and dosage form development of pharmaceuticals is also discussed.
Similar content being viewed by others
References
E.L. Paul, H.H. Tung, and M. Midler, Powd. Technol. 150 (2005) p. 133.
B.Y. Shekunov and P. York, J. Cryst. Growth 211 (2000) p. 122.
3. G. Desiraju, Crystal Engineering: The Design of Organic Solids (Elsevier, Amsterdam, 1989).
P. Erk, H. Hengelsberg, M.F. Haddow, and R. Van Gelder, Cryst. Eng. Comm. 6 (2004) p. 474.
M. Volmer, Kinetik der Phasenbildung (Steinkopff, Germany, 1939).
D.W. Oxtoby, Acc. Chem. Res. 31 (1998) p. 91.
P.G. Vekilov, Cryst. Growth Des. 4 (2004) p. 671.
F. Schuth, Curr. Opin. Solid State Mater. Sci. 5 (2001) p. 389.
D.W. Oxtoby, Philos. Trans. R. Soc. London, Ser. A. 361 (2003) p. 419.
P.R. ten Wolde and D. Frenkel, Science 277 (1997) p. 1975.
J.D. Shore, D. Perchak, and Y. Shnidman, J. Chem. Phys. 113 (2000) p. 6276.
O. Galkin and P.G. Vekilov, J. Am. Chem. Soc. 122 (2000) p. 156.
S. Chattopadhyay, D. Erdemir, J.M.B. Evans, J. Ilavsky, H. Amenitsch, C.U. Segre, and A.S. Myerson, Cryst. Growth. Des. 5 (2005) p. 523.
M. Kimura, Cryst. Growth Des. 6 (2006) p. 854.
B.A. Garetz, J. Matic, and A.S. Myerson, Phys. Rev. Lett. 89 175501 (2002).
R.J. Davey, K. Allen, N. Blagden, W.I. Cross, H.F. Lieberman, M.J. Quayle, S. Righini, L. Seton, and G.J.T. Tiddy, Cryst. Eng. Comm. 4 (2002) p. 257.
R. Hilfiker, Ed., Polymorphism in the Pharmaceutical Industry (John Wiley & Sons, Chichester, 2006); G. Winter, in Reactivity of Molecular Solids, edited by E.V. Boldyreva and V.V. Boldyrev (John Wiley & Sons, Chichester, 1999) p. 241.
J. Bernstein, Polymorphism in Molecular Crystals (Oxford University Press, New York, 2002).
J.O. Henck, U.J. Griesser, and A. Burger, Pharm. Ind. 59 (1997) p. 165.
M.R. Caira, in Topics in Current Chemistry, Vol. 198, edited by E. Weber (Springer, New York, 1998) p. 163.
S. Briancon and H. Fessi, STP Pharma. Prat. 13 (2003) p. 215; E. Doelker, STP Pharma. Prat. 9 (1999) p. 399.
C. Sun and D.J.W. Grant, Pharm. Res. 18 (2001) p. 274; C. Sun and D.J.W. Grant, Pharm. Res. 21 (2004) p. 382.
X. Chen, K.R. Morris, U.J. Griesser, S.R. Byrn, and J.G. Stowell, J. Am. Chem. Soc. 124 (2002) p. 15012.
J.D. Dunitz and J. Bernstein, Acc. Chem. Res. 28 (1995) p. 193.
A. Gavezzotti and G. Filippini, J. Am. Chem. Soc. 117 (1995) p. 12299.
J. Bauer, S. Spanton, R. Henry, J. Quick, W. Dziki, W. Porter, and J. Morris, Pharm. Res. 18 (2001) p. 859.
J.K. Guillory, in Polymorphism in Pharmaceutical Solids, edited by H.G. Brittain (Marcel Dekker, New York, 1999) p. 183; M. Maiwald, Am. Pharm. Rev. 9 (2006) p. 95.
M. Janik, Z. Malarski, J. Mrozinski, J. Wajcht, and Z. Zborucki, J. Crystallogr. Spectrosc. Res. 21 (1991) p. 519.
S.L. Morissette, O. Almarsson, M.L. Peterson, J.F. Remenar, M.J. Read, A.V. Lemmo, S. Ellis, M.J. Cima, and C.R. Gardner, Adv. Drug Delivery Rev. 56 (2004) p. 275.
H. Furedi-Milhofer, N. Garti, and A. Kamyshny, J. Cryst. Growth 198–199 (1999) p. 1365.
J.M. Ha, J.H. Wolf, M.A. Hillmyer, and M.D. Ward, J. Am. Chem. Soc. 126 (2004) p. 3382.
A.Y. Lee, I.S. Lee, S.S. Dette, J. Boerner, and A.S. Myerson, J. Am. Chem. Soc. 127 (2005) p. 14982.
C.P. Price, A.L. Grzesiak, and A.J. Matzger, J. Am. Chem. Soc. 127 (2005) p. 5512.
R. Hiremath, J.A. Basile, S.W. Varney, and J.A. Swift, J. Am. Chem. Soc. 127 (2005) p. 18321.
S. Chen, H. Xi, and L. Yu, J. Am. Chem. Soc. 127 (2005) p. 17439.
M.C. Meyer, A.B. Straughn, E.J. Jaryi, G.C. Wood, F.R. Pelsor, and V.P. Shah, Pharm. Res. 9 (1992) p. 1612.
S.L. Price, Adv. Drug. Delivery Rev. 56 (2004) p. 301.
R. Docherty and P. Meenan, in Molecular Modeling Applications in Crystallization, edited by A.S. Myerson (Cambridge University Press, Cambridge, 1999) p. 106.
P. Verwer and F.J.J. Leusen, in Reviews in Computational Chemistry, Vol. 12, edited by K.B. Lipkowitz and D.B. Boyd (John Wiley & Sons, New York, 1998) p. 327; R.J. Gdanitz, Curr. Opin. Solid State Mater. Sci. 3 (1998) p. 414.
J.P.M. Lommerse, W.D.S. Motherwell, H.L. Ammon, J.D. Dunitz, A. Gavezzotti, D.W.M. Hofmann, F.J.J. Leusen, W.T.M. Mooij, S.L. Price, B. Schweizer, M.U. Schmidt, B.P van Eijck, P. Verwer, and D.E. Williams, Acta Crystallogr., Sect. B: Struct. Sci. 56 (2000) p. 697; W.D.S. Motherwell, H.L. Ammon, J.D. Dunitz, A. Dzyabchenko, P. Erk, A. Gavezzotti, D.W.M. Hofmann, F.J.J. Leusen, J.P.M. Lommerse, W.T.M. Mooij, P. Verwer, and D.E. Williams, Acta Crystallogr., Sect. B: Struct. Sci. 58 (2002) p. 647; G.M. Day, W.D.S. Motherwell, H.L. Ammon, S.X.M. Boerrigter, R.G. Della Valle, E. Venuti, A. Dzvabchenko, J.D. Dunitz, B. Schweizer, B.P. van Eijck, P. Erk, J.C. Facelli, V.E. Bazterra, M.B. Ferraro, D.W.M. Hofmann, F.J.J. Leusen, C. Liang, C.C. Pantelides, P.G. Karamertzanis, S.L. Price, T.C. Lewis, H. Nowell, A. Torrisi, H.A. Scheraga, Y.A. Arnautova, M.U. Schmidt, and P. Verwer, Acta Crystallogr., Sect. B: Struct. Sci. 61 (2005) p. 511.
S.L. Price, in Reviews in Computational Chemistry, Vol. 14, edited by K.B. Lipkowitz and D.B. Boyd (John Wiley & Sons, New York, 2000) p. 225.
T. Beyer, T. Lewis, and S.L. Price, Cryst. Eng. Comm. 44 (2001) p. 1.
J.D. Dunitz, Chem. Commun. (2003) p. 545.
J.K. Haleblian, J. Pharm. Sci. 64 (1975) p. 1269.
E.M. Walker, K.J. Roberts, and S.J. Maginn, Langmuir 14 (1998) p. 5620.
I. Weissbuch, R. Popovitz-Biro, M. Lahav, and L. Leiserowitz, Acta Crystallogr., Sect. B: Struct. Sci. 51 (1995) p. 115.
L. Addadi, S. Weinstein, E. Gati, I. Weissbuch, and M. Lahav, J. Am. Chem. Soc. 104 (1982) p. 4610.
L. Addadi, Z. Berkovitch-Yellin, I. Weissbuch, M. Lahav, and L. Leiserowitz, Mol. Cryst. Liq. Cryst. 96 (1982) p. 1.
R.J. Davey, N. Blagden, G.D. Potts, and R. Docherty, J. Am. Chem. Soc. 119 (1997) p. 1767; T. Mukuta, A.Y. Lee, T. Kawakami, and A.S Myerson, Cryst. Growth Des. 5 (2005) p. 1429.
L. Addadi, Z. Berkovitch-Yellin, N. Domb, E. Gati, M. Lahav, and L. Leiserowitz, Nature 296 (1982) p. 21.
B. Kahr and R.W. Gurney, Chem. Rev. 101 (2001) p. 893.
H. Colfen and L. Qi, Chem. Eur. J. 7 (2001) p. 106.
A. Kuldipkumar, Y.T.F. Tan, M. Goldstein, Y. Nagasaki, G.G.Z. Zhang, and G.S. Kwon, Cryst. Growth Des. 5 (2005) p. 1781.
N. Rasenack and B.W. Muller, Int. J. Pharm. 244 (2002) p. 45.
G.M. Khan and Z. Jiabi, Drug Dev. Ind. Pharm. 24 (1998) p. 463.
W.M.L. Wood, Powd. Technol. 121 (2001) p. 53.
V. Chikhalia, R.T. Forbes, R.A. Storey, and M. Ticehurst, Eur. J. Pharm. Sci. 27 (2006) p. 19.
X.M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard, Int. J. Pharm. 200 (2000) p. 93.
M. Brunsteiner and S.L Price, Cryst. Growth Des. 1 (2001) p. 447.
X.Y. Liu, E.S. Boek, W.J. Briels, and P. Bennema, Nature 374 (1995) p. 342; D. Winn and M.F. Doherty, AIChe J. 44 (1998) p. 2501.
S.X.M. Boerrigter, H.M. Cuppen, R.I. Ristic, J.N. Sherwood, P. Bennema, and H. Meekes, Cryst. Growth. Des. 2 (2002) p. 357.
Z. Berkovitch-Yellin, J. Am. Chem. Soc. 107 (1985) p. 8239.
P. Mougin, G. Clydesdale, R.B. Hammond, and K.J. Roberts, J. Phys. Chem. B 107 (2003) p. 13262.
A.J. Hickey, ed., Pharmaceutical Inhalation Aerosol Technology (Marcel Dekker, New York, 1992).
C.A. Lipinski, Am. Pharm. Rev. 5 (2002) p. 82.
D. Horn and J. Rieger, Angew. Chem. Int. Ed. 40 (2001) p. 4330.
G.G. Liversidge and K.C. Cundy, Int. J. Pharm. 125 (1995) p. 91.
T.P. Shakhtshneider and V.V. Boldyrev, in Reactivity of Molecular Solids, edited by E.V. Boldyreva and V.V. Boldyrev (John Wiley & Sons, Chichester, 1999) p. 271.
J.E. Kipp, Int. J. Pharm. 284 (2004) p. 109; B.E. Rabinow, Nat. Rev. Drug Disc. 3 (2004) p. 785.
M. Midler Jr., E.P. Paul, E.F. Whittington, M. Futran, P.D. Liu, J. Hsu, and S.H. Pan, “Crystallization method to improve crystal structure and size,” U.S. Patent No. 5,314,506 (May 24, 1994).
P. York, U.B. Kompella, and B.Y. Shekunov, eds., Supercritical Fluid Technology for Drug Product Development (Marcel Dekker, New York, 2004).
M. Sacchetti and M.M. Van Oort, in Inhalation Aerosols, edited by A.J. Hickey (Marcel Dekker, New York, 1996) p. 337.
J. Yano, H. Furedi-Milhofer, E. Wachtel, and N. Garti, Langmuir 16 (2000) p. 10005.
A.I. Kitaigorodsky, Molecular Crystals and Molecules (Academic Press, New York, 1973).
J.W. Mullin, Crystallization (Butterworth-Heinemann, Boston, 2001).
A.Y. Lee, I.S. Lee, and A.S. Myerson, Chem. Eng. Technol. 29 (2006) p. 281.
Rights and permissions
About this article
Cite this article
Lee, A.Y., Myerson, A.S. Particle Engineering: Fundamentals of Particle Formation and Crystal Growth. MRS Bulletin 31, 881–886 (2006). https://doi.org/10.1557/mrs2006.207
Published:
Issue Date:
DOI: https://doi.org/10.1557/mrs2006.207